Diabetes treatment undermined by drug and disease interactions

The effective treatment of diabetes is hampered by the presence of other diseases and drugs, a study has shown.

Multiple diseases may hamper effective blood glucose control
Multiple diseases may hamper effective blood glucose control

Comorbid conditions and their treatments may affect how many patients with type 2 diabetes have well-controlled blood glucose levels, researchers found.

They said GPs needed guidelines that address patients who have multiple diseases.

Only half of patients with type 2 diabetes achieve recommended HbA1c levels of under 7%. One reason may be the high incidence of comorbid conditions, present in half of all patients with chronic diseases, and interactions with other drugs.

Most clinical guidelines focus on single diseases and there is little to guide GPs through complex interactions between comorbidities and comedication, the researchers said.

To examine the possible impact of these interactions, a team from the University of Leuven in Belgium analysed treatment outcomes in 3,416 patients with type 2 diabetes from 55 general practices.

They analysed patients’ HbA1c levels between 1994 and 2008, comparing patients who had type 2 diabetes with those who had comorbid diseases. These included joint disorders, respiratory disease, anaemia, malignancy or depression. Many patients were also prescribed at least one NSAID, corticosteroid or antidepressant.

Patients taking drugs for diabetes were 57% more likely to have poor glucose control if they also had a joint disorder. Patients with joint disorders and respiratory disease were 34% more likely to see worsening of HbA1c. Anaemia, malignancy and depression had no effect.
Patients on corticosteroids and NSAIDs were also more likely to have poor blood glucose control.

The study authors said their findings confirmed the need for ‘comprehensive guidelines’ to care for patients with multiple diseases. ‘These guidelines should be as generic as possible but could include adapted metabolic targets discussed on the basis of patient-specific treatment goals,’ they said.

Future research must study more combinations of chronic diseases and drug therapies to improve the chance of successful diabetes treatment, they added.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Subject access requests to GP practices increased by a third under GDPR

Subject access requests to GP practices increased by a third under GDPR

The number of subject access requests (SARs) GP practices receive each month has...

RCGP criticises GP at Hand video showing antibiotics prescribed for sore throat

RCGP criticises GP at Hand video showing antibiotics prescribed for sore throat

A promotional video for Babylon GP at Hand that shows a patient with a sore throat...

Review into overprescribing aims to give GPs power to challenge hospital scrips

Review into overprescribing aims to give GPs power to challenge hospital scrips

A government review of overprescribing in the NHS could see GPs given more power...

Submit your session ideas for the RCGP Annual Conference 2019

Submit your session ideas for the RCGP Annual Conference 2019

GPs can now submit ideas for sessions at the RCGP Annual Conference in Liverpool,...

Scottish GP workforce increases for first time in 10 years, figures show

Scottish GP workforce increases for first time in 10 years, figures show

GP numbers in Scotland have risen slightly for the first time in 10 years despite...

More than 16m GP practice appointments a year lost to DNAs

More than 16m GP practice appointments a year lost to DNAs

More than 16m appointments at GP practices are lost every year because patients fail...